Aripiprazole in the Treatment of Bipolar Depression
| Status: | Completed |
|---|---|
| Conditions: | Depression, Psychiatric, Bipolar Disorder |
| Therapuetic Areas: | Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - 64 |
| Updated: | 4/19/2017 |
| Start Date: | April 2004 |
| End Date: | February 2008 |
Phase 4 Study: An Open Prospective Study of the Safety and Effectiveness of Aripiprazole in the Treatment of Bipolar Depression
A systematic open-label prospective pilot study to assess aripirazole for acute bipolar
depression, with a secondary assessment of longer-term mood stabilization.
depression, with a secondary assessment of longer-term mood stabilization.
Study is 6 weeks long with 7 clinical visits.
Inclusion Criteria:
- DSM-IV diagnosis of bipolar disorder, any subtype; MADRS >16; MRS < 10; not currently
taking other mood stabilizers; women of reproductive potential must use an acceptable
method of birth control
Exclusion Criteria:
- Current substance abuse within past month; serious unstable medical condition; active
suicidal ideation; pregnant, trying to become pregnant, or nursing; intent to
continue or initiate herbal preparations
We found this trial at
1
site
Click here to add this to my saved trials
